Podcast

Stages of the Lifecycle and Risk for Onset and Progression of Diabetes

Janet Richard Events of Harvard Medical School presented in utero and early childhood development and the effects of diabetes risk at the 2010 ADA conference.

Janet Richard Events, director of developmental epidemiology at the Connor's Center for Women's Health and Gender Biology at Birgham and Women's Hospital at Harvard Medical School, presented in utero and early childhood development and the effects of diabetes risk.

Click here to access this podcast.

Related Videos
Advocating for Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
Skin of Color Savvy: The Art and Science of Treating Patients of Color
Looking at This Year in Pulmonology: A Lungcast 2024 Recap
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Related Content
Merck Halts Phase 3 HYPERION Trial of Sotatercept for Final Analysis| Image Credit: University of Michigan
January 30th 2025

Merck Halts Phase 3 HYPERION Trial of Sotatercept for Final Analysis

Connor Iapoce
Ep 16: A Look at Qlosi for Presbyopia with Elad Kedar, MBA| Image Credit: HCPLive
January 28th 2025

New Insight: A Look at Qlosi for Presbyopia with Elad Kedar, MBA

Veeral Sheth, MD, MBA, FASRS, FACS Connor Iapoce
FDA Grants 510(k) Clearance to First Lp(a) Blood Test in Molar Units | Image Credit: US Food and Drug Administration
January 29th 2025

FDA Grants 510(k) Clearance to First Lp(a) Blood Test in Molar Units

Connor Iapoce
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics| Image Credit: HCPLive
January 23rd 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
FDA black and white logo | Credit: US Food and Drug Administration
January 28th 2025

FDA Approves Semaglutide (Ozempic) for Type 2 Diabetes, Chronic Kidney Disease

Abigail Brooks, MA
FDA Accepts New Drug Application for Bumetanide Nasal Spray | Image Credit: US Food and Drug Administration
January 27th 2025

FDA Accepts New Drug Application for Bumetanide Nasal Spray

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.